Category: Newsletters

Blue Horseshoe Stocks: VLTC Recap & More

Voltari Corp. VLTC

A unique opportunity presented itself when billionaire activist investor Carl Icahn disclosed his increased position in VLTC (52% ownership) on April 1st. We tagged the stock in our premarket report that morning as it was gapping up, and have become more and more pleased with that decision as time goes on.

After witnessing a low of 2.18 the following day, it has been mostly northward movement as the stock has slowly but surely made its way to impressive new highs. We’ve been tracking it all along the way, with routine followup mentions on the 8th, 10th, 16th, and again in yesterday’s report.

During yesterday’s session VLTC made a nice move from a low of 8.75 to a new 52-week high of 10.41 at the close. It marked a healthy intraday run of 19%, and represents an overall increase of 377% from our observed low on April 2nd.

Anyone trading in this play has certainly thought of taking profits by this point, and reasonably so. That being said, with a high-profile investor like Icahn involved, we’ll have to be sure we don’t let VLTC slip off of our radars as we go forward.

When we finally do see a consolidation off of this historic run, we’ll immediately transition into bottom-watch mode and lay in wait for a subsequent rebound.

Pazoo, Inc. PZOO

We also want to give a quick update on PZOO, which as our readers are aware, we’ve been tracking pretty heavily in recent weeks. Like VLTC, it was also April 1st that we re-introduced this one into the mix. We’ve witnessed many intraday swings since then, that have offered multiple opportunities for successful trades.

Yesterday, the stock made its way from a daily low .0093 and spiked 18% to a new high of .011. That means that from the low of .0049 we observed on April 6th, PZOO had increased by a total of 124% It also closed at .0105; we’d like to see the stock work toward building a base of support at that key penny-level, however on any potential pullbacks we’ll want to see it hold support at or above the channel between the current 50DMA of .0074 and .008.

As we mentioned yesterday, we’re still rather “high” on marijuana-related stocks and PZOO remains one of our favorite ones, in its unique niche of medical cannabis testing/analysis.

Extended Watchlist:
LRCX, MYL, BIOC, BCLI, IBIO, LRE, TWDL, WSTI

Blue Horseshoe Stocks: Big Day for Cannabis Stocks & More

April 20th is here, and it marks a symbolic day for the legal cannabis sector. Our regular readers know that we’ve been following this relatively new market space since its inception. Public opinion on marijuana reform has shifted drastically over the past few years, and the signs are everywhere.Mainstream media has long since jumped on the pot bandwagon, airing numerous specials on the subject, like CNN with Dr. Sanjay Gupta’s “Weed” series, the third installment of which aired last night.

It is also likely that the cannabis issue will be thrust even further into the spotlight as it has the potential to take a significant role in the 2016 presidential elections.

We’ll be sure to follow along as we’ve been doing, all the while keeping our eyes open for potential plays in the space. We’ve got a couple popping up on the radar this morning.

ENDEXX Corp. EDXC

We’re taking notice of EDXC, whose recently acquired business has been presenting at the High Times Cannabis Cup in Denver which was in full swing over the weekend, and runs through the end of today.

The stock is coming off of a recent bottom and has been holding above its 50DMA since the end of March when the company’s acquisition of CBD Health Solutions was announced.

We’ll have this one on watch as the chart and the company’s activities both seem to have potential.

CAVE CREEK, AZ–(Marketwired – Apr 20, 2015) – Endexx Corporation’s (OTC PINK: EDXC) newly acquired subsidiary CBD Health Solutions LLC., has a booth in tent S4 at the annual Cannabis Cup in Denver, CO, through April 20th. Early reports are showing excellent reviews of the sample products and sales have been generated. The CBD Health Solutions’ team has been canvassing multiple markets over the past 90 days and sales contracts are growing on a weekly basis. >> FULL PR

FutureWorld Corp. FWDG

FWDG is another cannabis-related play that caught our eye this morning.

The company released a PR announcing an upcoming share dividend (Link below); since it isn’t uncommon to see stocks make a run into dividend dates, we’re going to monitor FWDG in the time between now and April 30th.

Chartwise, we’d like to see the stock get back above the 50DMA (.004). There’s a gap to the downside between .0024-.0028, so the possibility that it come come down to fill that gap before we see a rebound is certainly possible.

Easton Pharmaceuticals, Inc. EAPHEAPH is a play that we’ve been familiar with in the past; we’ve witnessed it produce huge gains on multiple occasions including a massive 1848% run from .0041-.0799 back in January-February 2014.

Then again from December ’14 to January of this year, the stock ran big in a range from .006-.0353, yielding potential gains in the neighborhood of 485%

The company released some very exciting news this morning pertaining to the purchase of a recreational marijuana facility in Colorado, so we’ll want to keep a close eye on this play as well into the foreseeable future.

Extended Watchlist:
GRPN, VLTC, HQCL, OCN, PVCT, CYCC

Blue Horseshoe Stocks: PMCB Update & More

PharmaCyte Biotech, Inc. PMCB

When we released a special report on PMCB back on Tuesday of last week, we commented on the promising nature of trials the company currently has underway relating to various treatments based on its Cell-in-a-Box® technology.

At the end of last week, PharmaCyte announced some promising research specifically pertaining to its diabetes treatment, with the claim that it can actually reverse Type-1 Diabetes in mice.The full paper can be found at http://www.nature.com/articles/mtm201511. Human trials are the next step to take, and needless to say, should the treatment prove effective using PMCB’s encapsulation technology (that we described in our initial report,) acquisition by a large pharmaceutical company could become a very real possibility.

That also seems to be the thinking on the Street, as PMCB has made some impressive strides on the chart over the past several sessions. From the low of .12 that we observed in this play on 04/08, it has made its way up as high as .22; a respectable 83% overall increase. That impressive high came during yesterday’s session in conjunction with a breach of the current 200DMA of .19.

PMCB will be one that we want to keep on continuous watch due to its potentially industry-disruptive diabetes treatment.

Pazoo, Inc. PZOO

PZOO has been a flipper’s dream since we re-initiated coverage on it just a couple of weeks ago. Yesterday’s low registered as .008 before the stock bounced back to .0097, a 21% intraday swing.

It was the same story on Wednesday; we saw PZOO dip to a low of .0074 before returning as high as .0103 (+39%) We’ve continually stated that we’d like to see the stock trading at or above the .008 range which, for the most part, it has continued to do.

CEO David Cunic appeared in an audio interview yesterday, and this morning we’re seeing another PR directing our attention to an 8-K filing which outlines a recent agreement, among other things, so our readers might want to check out those links.

In the meantime, we’ll be on the lookout for upcoming intraday gain opportunities from PZOO, such as those that it has delivered numerous time over the past several sessions.

Identiv, Inc. INVE

We also want to make a quick mention of INVE, which made a solid 14% move yesterday as it traded in a range from 11.12-12.67. It came on over ten times the 3-month average volume, so we’ll be observing this one as the week draws to a close, and possibly into next week.

Extended Watchlist:
RXII, ONCY, ZBB, UNXL